CEVEC

Nicole Faust, Ph.D., CEO
Cologne, Germany
(Private)
CEVEC Pharmaceuticals is a leading provider of high performance cell technology for the manufacturing of advanced biotherapeutics from R&D to manufacturing scale. The company’s portfolio comprises platform technologies for gene therapy viral vectors, viral vaccines, Exosomes and complex recombinant proteins. ELEVECTA® is specifically designed for AAV manufacturing, while CAP® addresses Adenoviral vectors, Lentiviral vectors, Oncolytic viruses, and Exosomes.
www.cevec.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions